Drugs · acquisition-cost intelligence
phenylephrine hydrochloride
· ingredient phenylephrineAdrenergic and dopaminergic agents· PHENYLEPHRINE HYDROCHLORIDE 100 mg/mL; PHENYLEPHRINE HYDROCHLORIDE 25 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$5.32
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other phenylephrine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Crane Safety Sinus Decongestant | $0.05196 | −$5.27 |
| 4 Way Fast Acting | $0.08423 | −$5.24 |
| phenylephrine hydrochloride | $9.08 | +$3.76 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.